Showing results (111-120 of 171) with videos related to

Sort By:
Pageof 18
International Journal of Hematology|August 28, 2013
WT1 mutation in pediatric patients with acute myeloid leukemia: a report from the Japanese Childhood AML Cooperative Study GroupHirozumi Sano, Akira Shimada, Ken Tabuchi, et al.
International Journal of Hematology|May 25, 2010
Prognostic significance of the BAALC isoform pattern and CEBPA mutations in pediatric acute myeloid leukemia with normal karyotype: a study by the Japanese Childhood AML Cooperative Study GroupYasuhiro Mizushima, Tomohiko Taki, Akira Shimada, et al.
The Journal of Biological Chemistry|August 1, 2008
Fusion of OTT to BSAC results in aberrant up-regulation of transcriptional activityTaisuke Sawada, Chiharu Nishiyama, Takuma Kishi, et al.
British Journal of Haematology|July 22, 2014
Acute myeloid leukaemia with myelodysplastic features in children: a report of Japanese Paediatric Leukaemia/Lymphoma Study GroupAkitoshi Kinoshita, Hayato Miyachi, Hiromichi Matsushita, et al.
British Journal of Haematology|February 21, 2019
Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 studyTakako Miyamura, Hiroshi Moritake, Hideki Nakayama, et al.
British Journal of Haematology|October 16, 2019
Patients aged less than 3 years with acute myeloid leukaemia characterize a molecularly and clinically distinct subgroupYusuke Hara, Norio Shiba, Genki Yamato, et al.
Genes, Chromosomes & Cancer|May 1, 2013
NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemiaNorio Shiba, Hitoshi Ichikawa, Tomohiko Taki, et al.
Oncotarget|June 5, 2018
PPP2R1A regulated by PAX3/FOXO1 fusion contributes to the acquisition of aggressive behavior in PAX3/FOXO1-positive alveolar rhabdomyosarcomaKeisuke Akaike, Yoshiyuki Suehara, Shinji Kohsaka, et al.
British Journal of Haematology|December 20, 2015
High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 trialNorio Shiba, Kentaro Ohki, Tohru Kobayashi, et al.
Pediatric Blood & Cancer|July 2, 2024
High DOCK1 expression identifies a distinct prognostic subgroup of pediatric acute myeloid leukemia: Results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trialMasahiro Yoshitomi, Shin-Ichi Tsujimoto, Junji Ikeda, et al.
Pageof 18